In a cohort of 52 UK patients presenting with primary UM, high immunohistochemical expression of CysLT1 was significantly associated with reduced survival from metastatic disease and reduced overall survival, as assessed by both manual and digital pathology analysis (18). The gene discussed is CYSLTR1; the disease is metastatic neoplasm.